Protected pages

Jump to navigation Jump to search

This page lists existing pages that are currently protected. For a list of titles that are protected from creation, see Protected titles.

Protected pages
First pagePrevious pageNext pageLast page
Timestamp Page Expires Protecting user Protection parameters Reason
Unknown The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Aspirin Suggest Revisions to the CLASS I Guidelines 2,425 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Aspirin Suggest Revisions to the CLASS IIa Guidelines 2,085 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel Suggest Revisions to the CLASS I Guidelines 3,495 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel Suggest Revisions to the CLASS IIa Guidelines 2,157 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Warfarin Suggest Revisions to the CLASS I Guidelines 4,622 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Recommendations for Beta Blocker Therapy Suggest Revisions to the CLASS IIa Guidelines 2,668 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Recommendations for Beta Blocker Therapy Suggest Revisions to the CLASS III Guidelines 2,612 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Recommendations for ACE Inhibitors Therapy Suggest Revisions to the CLASS I Guidelines 3,634 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Recommendations for ACE Inhibitors Therapy Suggest Revisions to the CLASS IIa Guidelines 2,172 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Recommendations for Angiotensin Receptor Blockers Therapy Suggest Revisions to the CLASS I Guidelines 3,298 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Recommendations for Aldosterone Blockers Therapy Suggest Revisions to the CLASS I Guidelines 2,168 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Influenza Vaccination Suggest Revisions to the CLASS I Guidelines 1,988 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Reperfusion Suggest Revisions to the CLASS I Guidelines 3,481 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Facilitated PCI Suggest Revisions to the CLASS IIb Guidelines 2,260 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Facilitated PCI Suggest Revisions to the CLASS III Guidelines 2,023 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Immediate (or Emergency) Invasive Strategy and Rescue PCI Suggest Revisions to the CLASS I Guidelines 4,434 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Immediate (or Emergency) Invasive Strategy and Rescue PCI Suggest Revisions to the CLASS IIa Guidelines 5,969 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Immediate (or Emergency) Invasive Strategy and Rescue PCI Suggest Revisions to the CLASS IIb Guidelines 2,268 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Immediate (or Emergency) Invasive Strategy and Rescue PCI Suggest Revisions to the CLASS III Guidelines 2,189 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI PCI after Successful Fibrinolysis or for Patients not Undergoing Primary Reperfusion Suggest Revisions to the CLASS IIb Guidelines 2,058 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI PCI after Successful Fibrinolysis or for Patients not Undergoing Primary Reperfusion Suggest Revisions to the CLASS III Guidelines 2,179 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Anticoagulants for STEMI patients who do not go reperfusion therapy Suggest Revisions to the CLASS III Guidelines 2,108 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Anticoagulants for STEMI patients who do not go reperfusion therapy Suggest Revisions to the CLASS IIa Guidelines 4,381 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Anticoagulants as Ancillary Therapy Suggest Revisions to the CLASS I Guidelines 13,288 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Thienopyridines Suggest Revisions to the CLASS I Guidelines 3,486 bytes infinite Unknown user semi protected —
Unknown The Living Guidelines: STEMI Thienopyridines Suggest Revisions to the CLASS IIa Guidelines 3,515 bytes infinite Unknown user semi protected —
Unknown Guidelines for atrial fibrillation 84 bytes infinite Unknown user fully protected —
Unknown The Living Guidelines: Initial Conservative versus Initial Invasive Strategies in patients with Unstable Angina / Non ST Elevation MI View the Current CLASS I Guidelines 18,135 bytes infinite Unknown user fully protected —
Unknown Propranolol precautions 34 bytes infinite Unknown user fully protected —
Unknown Propranolol side effects 43 bytes infinite Unknown user fully protected —
Unknown Propranolol how supplied 38 bytes infinite Unknown user fully protected —
Unknown Propranolol pharmacokinetics and molecular data 38 bytes infinite Unknown user fully protected —
Unknown Metoprolol indications 1,288 bytes infinite Unknown user fully protected —
Unknown Atenolol pharmacokinetics and molecular data 35 bytes infinite Unknown user fully protected —
Unknown Atenolol instructions for administration 53 bytes infinite Unknown user fully protected —
Unknown Atenolol drug interactions 121 bytes infinite Unknown user fully protected —
Unknown Metoprolol overdose 1,905 bytes infinite Unknown user fully protected —
Unknown Metoprolol how supplied 1,337 bytes infinite Unknown user fully protected —
Unknown Metoprolol pharmacokinetics and molecular data 12,725 bytes infinite Unknown user fully protected —
Unknown Diltiazem warnings 32 bytes infinite Unknown user fully protected —
Unknown Diltiazem side effects 41 bytes infinite Unknown user fully protected —
Unknown Diltiazem drug interactions 41 bytes infinite Unknown user fully protected —
Unknown Doxazosin indications 52 bytes infinite Unknown user fully protected —
Unknown Doxazosin side effects 41 bytes infinite Unknown user fully protected —
Unknown Doxazosin overdose 34 bytes infinite Unknown user fully protected —
Unknown Doxazosin how supplied 36 bytes infinite Unknown user fully protected —
Unknown Doxazosin pharmacokinetics and molecular data 40 bytes infinite Unknown user fully protected —
Unknown Doxazosin instructions for administration 53 bytes infinite Unknown user fully protected —
Unknown Clonidine precautions 32 bytes infinite Unknown user fully protected —
Unknown Clonidine side effects 41 bytes infinite Unknown user fully protected —
First pagePrevious pageNext pageLast page
Retrieved from "https://www.wikidoc.org/index.php/Special:ProtectedPages"